期刊文献+

青年人原发性肝癌24例诊疗分析 被引量:5

Analysis of diagnosis and treatment of young 24 cases with primary liver cancer
下载PDF
导出
摘要 目的:探讨青年原发性肝癌(PLC)的临床诊疗特点。方法:选择PLC患者80例,随机分为青年肝癌组(年龄〈40岁)24例,非青年肝癌组(年龄≥40岁)56例,比较分析2组的临床症状、肝脏功能、病理类型、术后并发症发生率等。结果:青年组缺乏特异性临床表现的比例较非青年组高(P〈0.05~P〈0.01),青年组胆管细胞癌比例较非青年组少(P〈0.05)。青年组肝脏功能较老年组好(P〈0.01),术后并发症发生率较非青年组低(P〈0.05)。结论:青年人肝癌起病隐匿,早期诊断率低,手术耐受性高,治疗应尽量采用以根治性肝切除为主的综合治疗,术后并发症发生率低。 Objective:To investigate the clinical features and treatment of young patients with primary liver cancer(PLC).Methods:A total of 80 cases of PLC were divided into 2 groups,young group(age40 years),24 cases;non-young group(age≥40 years),56 cases.The clinical symptoms,clinicopathologic features,clinical conditions of liver and the incidence of postoperative complications in the two groups were comparatively analyzed.Results:The cases in young group have less specific clinical manifestations than the cases in non-young group(P0.05-P0.01);cholangiocarcinoma in the young group are less than that in non-young group(P0.05),young group has a better liver fuction than that of non young group(P0.01).Postoperative complications rate in young group is lower than in non-young group(P0.05).Conclusions:Occult liver cancer onset,low early diagnosis and high operation tolerance occur in young PLC patients;surgery-predominant comprehensive therapy should be performed for young PLC patients to improve outcome.Low incidence of postoperative complications were also noted in young PLC patients.
出处 《蚌埠医学院学报》 CAS 2011年第4期361-362,365,共3页 Journal of Bengbu Medical College
关键词 肝肿瘤 青年 并发症 liver neoplasms young postoperative complications
  • 相关文献

参考文献10

  • 1孟炜,唐锦高,沈福民,蔡如琳,江峰,林文尧,姜庆五.原发性肝癌危险因素的巢式病例对照研究[J].复旦学报(医学版),2002,29(5):368-371. 被引量:7
  • 2Sezaki H,Kobayashi M,Hosaka T,et al.Hepatocellular carcinoma in noncirrhotic young adult patients with chronic hepatitis B viral infection[J].J Gastroenterol,2004,39 (6):550-556.
  • 3Lam CM,Chan AO,Ho P,et al.Different presentation of hepatitis B-related hepatocellular carcinoma in a cohort of 1863 young and old patients-implications for screening[J].Aliment Pharmacol Ther,2004,19 (7):771-777.
  • 4沈玲,方之勋,舒伟平.青年及老年原发性肝癌的临床分析[J].南京铁道医学院学报,2001,20(1):36-38. 被引量:1
  • 5Tsai FC,Liu CJ,Chen CL.Lower serum viral loads in young patients with hepatitis-B-virus-related hepatocellular carcinoma[J].J Viral Hepat,2007,14(3):153-160.
  • 6Carr BI,Pancoska P,Branch RA.HCC in young adults[J].Hepatogastroenterology,2010,57(99/100):436-440.
  • 7陈孝平,张志伟,杨甲梅,沈锋.肝细胞肝癌外科治疗方法的选择[J].腹部外科,2008,21(5):262-264. 被引量:12
  • 8Yamazaki Y,Kakizaki S,Sohara N.Hepatocellular carcinoma in young adults:the clinical characteristics,prognosis,and findings of a patient survival analysis[J].Dig Dis Sci,2007,52(4):1103-1107.
  • 9陈孝平,裘法祖,吴在德.原发性肝癌要按个体化采用以手术为主的综合治疗[J].中华外科杂志,2003,4(3):161-162. 被引量:50
  • 10Chang PE,Ong WC,Lui HF,et al.Is the prognosis of young patients with hepatocellular carcinoma poorer than the prognosis of older patients A comparative analysis of clinical characteristics,prognostic features,and survival outcome[J].J Gastroenterol,2008,43(11):881-888.

二级参考文献14

共引文献66

同被引文献29

  • 1王季堃,乔世峰.反义IGF-Ⅰ寡核苷酸转染抑制人肝癌细胞生长的实验观察[J].中国肿瘤临床,2005,32(2):115-116. 被引量:7
  • 2Livragi T, Giorgio A, Marin G, et al. Hepatocellular carcinioma and cirrhosis in 746 patients: Long-term results of percutaneous ethanolinjection [ J ]. Radiology, 1995,19 (7) : 101 - 108.
  • 3Kotoh K, Sakai H, Morotomi I, et al. The use of percutaneous ethanol injection therapy for recurrence of hepatocellular carcinoma [ J]. Hepatogastroenterolgy, 1995,4 ( 2 ) : 197 - 200.
  • 4Shina S,Tagawa K, Unuma T,et al. Percutaneous ethanol injection therapy of hepatocellular carcinoma : analysis of 77 patients [ J ]. AJR,1990,15(5) :1221 - 1224.
  • 5Bartolozzi C, Crocetti L, Cioni D,et al. An analysis of 412 cases of hepatoeellular carcinon a at a western center[ J]. Ann Surg, 1999, 299 (6) :790 - 800.
  • 6Lin S,Hoffmann K,Schemmer P. Treatment of hepatocellnlar carcinoma :a systematic review[ J]. Liver Cancer,2012,1 (3/4) : 144 - 158.
  • 7Vitale A,Boccagni P,Kertusha X,et al. Sorafenib for the treatment of re-current hepatocellular carcinoma after liver transplantation. [ J ] . Trans-plant Proc,2012,44(7) :1989 -991.
  • 8Park JW,Koh YH,Kim HB,et al. Phase II study of concurrent transarte-rial chemoembolization and sorafenib in patients with unresectable hepa-tocellular carcinoma[ J]. J Clin Oncol,2011,29(30) :3960 - 3967.
  • 9魏莉,王秀玲,郑娃.绿色方案治疗晚期肝癌的临床研究[J].中国健康,2011,30(11):55 -56.
  • 10Bhoori S,Tolfanin S,Sposito C, et al. Personalized molecular targetedtherapy in advanced,recurrent hepatocellular carcinoma after liver trans-plantation :a proof of principle [ J ]. J Hepatol ,2010,52(5) :(5) :771 -775.

引证文献5

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部